Evidence map›Paper›PMID 40036255›Full record

ArticleJournal of leukocyte biology2025

High-dimensional spectral flow cytometry of activation and phagocytosis by peripheral human polymorphonuclear leukocytes.

Evan R Lamb, Ian J Glomski, Taylor A Harper, Michael D Solga, Alison K Criss

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Evan R LambDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Box 800734, Charlottesville, VA 22908-0734, United States.
Ian J GlomskiDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Box 800734, Charlottesville, VA 22908-0734, United States.
Taylor A HarperFlow Cytometry Core Facility, University of Virginia School of Medicine, Box 800741, Charlottesville, VA 22908-0741, United States.
Michael D SolgaFlow Cytometry Core Facility, University of Virginia School of Medicine, Box 800741, Charlottesville, VA 22908-0741, United States.
Alison K CrissDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Box 800734, Charlottesville, VA 22908-0734, United States.ORCID 0000-0001-7738-3757

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
The Gonorrhea Vaccine Cooperative Research CenterU19AI144180 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI JERSE, ANN E. · 2019 to 2023
$10.7M
The Effects of Sex Hormones on Chlamydia InfectionU19AI158930 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CRISS, ALISON K · 2021 to 2025
$7.7M
Survival of Neisseria gonorrhoeae after primary human neutrophil challengeR01AI097312 · NIAID · UNIVERSITY OF VIRGINIA · PI CRISS, ALISON K · 2012 to 2022
$4.6M
Efficacy of immunization with 4C-MenB in preventing experimental urethral infection with Neisseria gonorrhoeae.U01AI162457 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2021 to 2025
$3.9M
Survival of Neisseria gonorrhoeae after primary human neutrophil challengeR37AI097312 · NIAID · UNIVERSITY OF VIRGINIA · PI Alison K Criss · 2025 to 2026
$1.1M
Defining mechanisms of complement-mediated killing of Neisseria gonorrhoeaeF30AI179038 · NIAID · UNIVERSITY OF VIRGINIA · PI LAMB, EVAN R · 2024 to 2025
$93k
FCCF SCR_017829NCI NIH HHS P30 CA044579NIAID NIH HHS F30 AI179038NIAID NIH HHS R01 AI097312NIAID NIH HHS R37 AI097312NIAID NIH HHS T32 AI007046NIAID NIH HHS U01 AI162457NIAID NIH HHS U19 AI144180NIAID NIH HHS U19 AI158930NIGMS NIH HHS T32 GM007267NIH HHS R01 AI097312UVA
6 · The paper itself

Abstract

Polymorphonuclear leukocytes (PMNs) are terminally differentiated phagocytes with pivotal roles in infection, inflammation, tissue injury, and resolution. PMNs display a breadth of responses to diverse endogenous and exogenous stimuli, making understanding of these innate immune responders vital yet challenging to achieve. Here, we report a 22-color spectral flow cytometry panel to profile primary human PMNs for surface marker expression of activation, degranulation, phagocytosis, migration, chemotaxis, and interaction with fluorescently labeled cargo. We demonstrate the surface marker response of PMNs to phorbol ester stimulation compared with untreated controls in an adherent PMN model with additional analysis of intra- and inter-subject variability. PMNs challenged with the Gram-negative bacterial pathogen Neisseria gonorrhoeae revealed infectious dose-dependent changes in surface marker expression in bulk, population-level analysis. Imaging flow cytometry complemented spectral cytometry, demonstrating that fluorescence signal from labeled bacteria corresponded with bacterial burden on a per-cell basis. Spectral flow cytometry subsequently identified surface markers, which varied with direct PMN-bacterium association as well as those which varied in the presence of bacteria but without phagocytosis. This spectral panel protocol highlights best practices for efficient customization and is compatible with downstream approaches such as spectral cell sorting and single-cell RNA-sequencing for applicability to diverse research questions in the field of PMN biology.

Indexed as

Flow CytometryNeutrophil ActivationNeutrophilsPhagocytosisBiomarkersHumansNeisseria gonorrhoeaeBiomarkersdegranulationimaging flow cytometryNeisseria gonorrhoeaeneutrophilspectral flow cytometry

Identifiers

PMID40036255
PMCPMC12031652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.